UNC, Duke seek volunteers, particularly people of color, for COVID-19 vaccine trials
UNC Health and the School of Medicine are looking for 500 people willing to test a potential vaccine for COVID-19, one of what could be several opportunities for Triangle residents to take part in vaccine clinical trials for coronavirus in the coming months.
This might be your most important flu shot ever
This fall and winter, health experts expect two types of deadly viruses to be circulating widely in the US. But they don’t yet know what the extent of the damage will be when the two collide.
Keeping a Close Watch on COVID-19 with Surveillance Tests
Duke Associate Professor of Biology Steve Haase likes to compare the spread of COVID-19 to the haphazard advance of a forest fire, where tiny glowing embers, which he likens to the virus, drift in the air, among trees bringing potential harm whatever they touch.
Duke Institute Tapped to Test Monoclonal Antibody Preventative for COVID-19
The Duke Human Vaccine Institute Pandemic Prevention Program (DHVI-P3) has received an additional $7.6 million in federal funding to manufacture and test in humans a neutralizing monoclonal antibody for the prevention of COVID-19.
Experts express doubts over Russia's vaccine claim
Russian President Vladimir Putin announced Tuesday that his country has developed the first-ever coronavirus vaccine, but many experts doubt its legitimacy.
Duke Team to Implement SARS-CoV-2 Neutralization Assay Concordance Survey in Laboratories Worldwide
The Duke EQAPOL/VQA team, led by Tom Denny in partnership with Dr. David Montefiori in the Department of Surgery, will implement a SARS-CoV-2 Neutralization Assay Concordance Survey (SNACS) in more than 50 participating laboratories worldwide.
Duke to Launch Phase 1 Trial of COVID-19 Treatment
DHVI is pleased to announce the approval of a Phase 1 clinical trial of one of our most promising antibody treatments for COVID-19.
School of Medicine Expands to RTP, January 2021
The Duke University School of Medicine is expanding into a newly-leased research center in the Research Triangle Park (RTP). The 273,000 square foot facility in the Parmer RTP research and development campus, formerly home to pharmaceutical maker GlaxoSmithKline, is currently being renovated to accommodate School of Medicine faculty, staff and labs as soon as January 2021.
COVID-19 Laboratory Challenges and Lessons: Part 1
The COVID-19 pandemic has impacted laboratories across the world. Some laboratories have been labeled non-essential and face the challenges of being forcibly idled. Other laboratories have been labeled essential and face the challenge of keeping workers safe and delivering for their stakeholders during this crisis.
COVID-19 Vaccine in 2020 Highly Unlikely, Experts Caution
peculation that a vaccine for COVID-19 might be widely available by the end of this year is overly optimistic, three Duke experts said Wednesday.